Literature DB >> 8431899

National survey of ovarian carcinoma. I. A patient care evaluation study of the American College of Surgeons.

H E Averette1, W Hoskins, H N Nguyen, G Boike, H C Flessa, J S Chmiel, K Zuber, L H Karnell, D P Winchester.   

Abstract

BACKGROUND: The Commission on Cancer of the American College of Surgeons recently finished a national survey of patients with ovarian cancer patients. The goal was to compare the patterns of care over a 5-year period.
METHODS: Data were collected from 25 consecutive patients whose disease was diagnosed first at 904 hospitals with cancer programs in 1983 and 1988.
RESULTS: There was a total of 12,316 patients, of whom 80% were 45-85 years old. Contrary to popular belief, only 8.2% of patients were nulliparous; 85% of patients had one to five children. Of significance, 18.2% of patients with ovarian cancer had undergone a previous hysterectomy with ovarian preservation. Primary surgical treatment was used in 94.9% of patients and consisted of: oophorectomy, 81.9%; hysterectomy, 55.1%; and omentectomy, 59.0%. However, only 12-25% of patients had biopsies of the diaphragm, paracolic gutters, colon, small bowel, pelvic and paraaortic lymph nodes, and cul-de-sac to permit adequate surgical staging. The primary surgeons were: gynecologic oncologists, 21%; obstetrician-gynecologists, 45%; general surgeons, 21%; and others, 13%.
CONCLUSIONS: These data indicate that additional resources are needed to improve the care of patients with ovarian cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8431899

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  The omentum.

Authors:  Cameron Platell; Deborah Cooper; John M Papadimitriou; John C Hall
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

2.  Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients.

Authors:  Paweł Surowiak; Verena Materna; Irina Kaplenko; Marek Spaczyński; Manfred Dietel; Hermann Lage; Maciej Zabel
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

3.  Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome.

Authors:  Paweł Surowiak; Verena Materna; Adam Maciejczyk; Marek Pudełko; Ewa Markwitz; Marek Spaczyński; Manfred Dietel; Maciej Zabel; Hermann Lage
Journal:  Virchows Arch       Date:  2007-01-19       Impact factor: 4.064

Review 4.  Ovarian cancer: the clinical role of US, CT, and MRI.

Authors:  Kaori Togashi
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

Review 5.  Surgery for elderly patients with ovarian cancer.

Authors:  Martin G A Bäuerle; Rolf Kreienberg; Tanja Volm
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

Review 6.  Cytoreductive surgery in ovarian cancer.

Authors:  Christophe Pomel; Arjun Jeyarajah; David Oram; John Shepherd; David Milliken; Jacques Dauplat; Karina Reynolds
Journal:  Cancer Imaging       Date:  2007-12-17       Impact factor: 3.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.